More top news

5:45pm, Mon 20 May 2013 Drug slows Parkinson's progress Last updated Mon 20 May 2013

A diabetes drug called Exenatide could be beneficial for the treatment of Parkinson's disease, new research has found.

This new study is perhaps more noteworthy for the approach it has taken with respect to the clinical trial design.

All of this was done in a modest number of patients and the results compared with a matched control arm that received best medical therapy.

Using this approach they found a signal of effect that suggested that the drug may well be slowing down the disease process.

All of which is good news not only for patients with PD but for us all, as we seek to explore how drugs already out there could be repositioned.

Jayne Torvill and Christopher Dean have told ITV's Daybreak that the popular show Dancing on Ice will finish after next year's series.

The death toll is climbing remorselessly. The sense of helplessness in Oklahoma is overwhelming.

A&Es are getting 'closer to the cliff edge' as ITV News has learned the Health Secretary is to unveil major reforms of Out of Hours care.

The common diabetes drug Exenatide could be beneficial for the treatment of Parkinson's disease, new research suggests.

More here:
More top news